Becton Dickinson earnings beat by $0.04, revenue topped estimates
Investing.com – Becton Dickinson (NYSE: BDX) reported fourth quarter EPS of $3.81, $0.04 better than the analyst estimate of $3.77....
Read more
Investing
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
By Patrick Wingrove (Reuters) – Moderna (NASDAQ:MRNA) reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected...
Read more
CVS taps former UnitedHealth executive to run insurance unit Aetna
By Amina Niasse and Sriparna Roy (Reuters) – CVS Health (NYSE:CVS) on Wednesday named Steve Nelson, a former UnitedHealth (NYSE:UNH)...
Read more
Trump 2.0 to be modest positive for BioPharma, BMO says, but watch FDA
Investing.com — Donald Trump’s return to the White House is expected to be a “modest positive” for the biopharma sector,...
Read more
Perrigo earnings missed by $0.02, revenue fell short of estimates
Investing.com – Perrigo (NYSE: PRGO) reported third quarter EPS of $0.81, $0.02 worse than the analyst estimate of $0.83. Revenue...
Read more
Explainer-How Trump’s second administration affects business: Musk, tariffs and more
(Reuters) – Donald Trump’s return to the White House after winning the Nov. 5 U.S. presidential election may reshape American...
Read more
US stock futures, dollar and bitcoin surge as Trump wins race to White House
By Dhara Ranasinghe LONDON (Reuters) – Major stock markets around the world rallied on Wednesday, while bitcoin hit a record...
Read more
Musk now says it’s ‘pointless’ to build a $25,000 Tesla for human drivers
By Chris Kirkham (Reuters) – When Reuters reported in April that Tesla (NASDAQ:TSLA) had scrapped plans for a long-promised, next-generation...
Read more
